(Q34623028)

English

Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

0 references

attention deficit hyperactivity disorder

0 references

1 reference

based on heuristic

inferred from title

Daniel F. Connor

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Robert L Findling

2

object named as

Robert L Findling

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Scott H Kollins

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Floyd Sallee

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Frank A López

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Andrew Lyne

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Gerald Tremblay

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

755-768

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20806988%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention-deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential diagnosis and comorbidity of attention-deficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD) in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The structure of oppositionality: response dispositions and situational aspects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulants: Therapeutic actions in ADHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, mul

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delineation of rat kidney α2A- and α2B-adrenoeeptors with [3H]RX821002 radiollgand binding: computer modelling reveals that guanfacine is an α2A-selective compound

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention-deficit/hyperactivity disorder evaluation and diagnosis: a practical approach in office practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention-deficit/hyperactivity disorder: a selective overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive dysfunction in attention-deficit/hyperactivity disorder: cognitive and neuroimaging findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The alpha-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behavior disorders?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20806988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34623028&oldid=2196878599"